Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials
Not Applicable
Withdrawn
- Conditions
- Assess the Patient Feeling About the Handiness of Two Different Vials Used to Deliver Both, Unpreserved Hyaluronic Eye Drops
- Registration Number
- NCT01546012
- Lead Sponsor
- Laboratoires Thea
- Brief Summary
Assess the patient feeling about the handiness of two different vials used to deliver both, unpreserved hyaluronic eye drops.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Man or woman aged 18 and older
- Patient with dry eye for at least 3 months
- Having given his written informed consent
Exclusion Criteria
- Intolerance to studied products
- Patient's inability to understand the study procedures and give informed consent.
- Patient unwilling to follow the study procedures and visits defined by the protocol.
- Pregnant or lactating women.
- Patient under guardian ship
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Overall preference of the patient 6 weeks At Visit2: Week 6 +/- 1week: End of Study Visit. "Overall preference of the patient": number of answers Hyabak, Hylo-comod.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of hyaluronic acid in unpreserved eye drops for ocular surface disorders?
How do HYABAK® and HYLO-COMOD® compare to standard-of-care preservatives in managing dry eye symptoms?
Are there specific biomarkers that correlate with improved patient satisfaction in hyaluronic acid formulations?
What adverse events are associated with hyaluronic acid eye drops and how are they managed in clinical practice?
What are the competitive advantages of HYABAK® and HYLO-COMOD® over other hyaluronic acid-based ophthalmic devices in terms of patient compliance and handiness?
Trial Locations
- Locations (1)
Augenklinik
🇩🇪Berlin, Germany
Augenklinik🇩🇪Berlin, Germany